IRIS
ARCESE, WILLIAM
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 64.853
AS - Asia 5.912
EU - Europa 5.021
SA - Sud America 1.050
AF - Africa 97
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 12
Totale 76.962
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 64.725
SG - Singapore 3.096
DE - Germania 1.172
CN - Cina 1.127
BR - Brasile 866
UA - Ucraina 795
HK - Hong Kong 746
IE - Irlanda 710
IT - Italia 709
RU - Federazione Russa 487
GB - Regno Unito 313
KR - Corea 285
VN - Vietnam 255
SE - Svezia 202
FI - Finlandia 180
FR - Francia 144
PL - Polonia 90
AR - Argentina 72
IN - India 70
CA - Canada 64
JP - Giappone 56
BD - Bangladesh 48
MX - Messico 43
NL - Olanda 42
ES - Italia 39
ZA - Sudafrica 38
AT - Austria 37
ID - Indonesia 28
UZ - Uzbekistan 26
IQ - Iraq 25
BE - Belgio 22
CO - Colombia 22
TR - Turchia 22
EC - Ecuador 21
MA - Marocco 20
CZ - Repubblica Ceca 16
PK - Pakistan 16
CL - Cile 14
EU - Europa 14
IR - Iran 14
PY - Paraguay 14
UY - Uruguay 13
VE - Venezuela 13
KE - Kenya 12
AE - Emirati Arabi Uniti 11
PE - Perù 11
AU - Australia 10
LT - Lituania 10
IL - Israele 9
MY - Malesia 9
SA - Arabia Saudita 9
BY - Bielorussia 8
KZ - Kazakistan 8
PH - Filippine 8
PA - Panama 7
AL - Albania 6
CH - Svizzera 6
DZ - Algeria 6
EG - Egitto 6
TN - Tunisia 6
TW - Taiwan 6
BG - Bulgaria 5
GR - Grecia 5
PT - Portogallo 5
RO - Romania 5
AZ - Azerbaigian 4
BO - Bolivia 4
DK - Danimarca 4
JO - Giordania 4
KG - Kirghizistan 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
JM - Giamaica 3
LB - Libano 3
LK - Sri Lanka 3
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
ET - Etiopia 2
GT - Guatemala 2
HN - Honduras 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
AO - Angola 1
BH - Bahrain 1
CM - Camerun 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GM - Gambi 1
HU - Ungheria 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
Totale 76.953
Salva come PNG Salva come JPEG
Città #
Wilmington 18.042
Woodbridge 17.268
Houston 16.045
Fairfield 2.127
Ann Arbor 1.508
Singapore 1.415
Ashburn 1.116
Chandler 949
Seattle 811
Hong Kong 734
Cambridge 727
Dublin 687
Jacksonville 683
Beijing 602
Medford 536
Dearborn 455
Santa Clara 304
New York 257
Lawrence 254
Rome 222
The Dalles 192
Los Angeles 180
San Diego 149
Moscow 135
Buffalo 130
Regensburg 128
Dallas 115
Mülheim 105
Ho Chi Minh City 85
Milan 84
São Paulo 73
Zhengzhou 68
Menlo Park 62
Munich 57
Hanoi 54
London 53
Norwalk 45
Kraków 42
Redwood City 39
Council Bluffs 38
Warsaw 38
Hefei 37
Redondo Beach 37
Falls Church 35
Guangzhou 34
University Park 34
Nuremberg 33
Nanjing 32
Boardman 30
Orem 30
Chicago 29
Hangzhou 29
Helsinki 27
Saint Petersburg 25
Seoul 25
Johannesburg 24
Kunming 24
Rio de Janeiro 24
Toronto 24
Denver 23
Redmond 23
Tokyo 23
Belo Horizonte 21
Brooklyn 20
Mountain View 20
Brussels 19
Poplar 19
Detroit 18
San Francisco 18
Atlanta 17
Verona 17
Jakarta 16
Nanchang 15
Shanghai 15
Tashkent 15
Brno 14
Elk Grove Village 14
Frankfurt am Main 14
Montreal 14
Columbus 13
Hounslow 13
Mumbai 13
Palo Alto 13
Phoenix 13
Brasília 12
Curitiba 12
Engelhard 12
Guarulhos 12
Indiana 12
Salvador 12
San Mateo 12
Vienna 12
Haiphong 11
Kilburn 11
Montevideo 11
New Delhi 11
Nürnberg 11
Ottawa 11
Rieti 11
Center 10
Totale 67.750
Salva come PNG Salva come JPEG
Nome #
Unrelated cord blood transplant in children with high-risk acute lymphoblastic leukemia: a long-term follow-up 666
Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia 588
Pre-transplant prognostic factors for patients with high-risk leukemia undergoing an unrelated cord blood transplantation 559
Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor 529
Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day+5 responders and no advantage for nonresponders receiving anti-thymocyte globulin 519
Peripheral blood stem cell collection from G-CSF-stimulated unrelated donors for second transplant 515
Bowel ultrasonography as an aid for diagnosis of intestinal acute graft-versus-host-disease after allogeneic haematopoietic stem cell transplantation 489
Hematopoietic stem cell transplantation for adults with acute promyelocytic leukemia in the ATRA era: a survey of the European Cooperative Group for Blood and Marrow Transplantation 474
High levels of antiphospholipid antibodies are associated with cytomegalovirus infection in unrelated bone marrow and cord blood allogeneic stem cell transplantation 467
High expression levels of vla-4 (CD49d) on mobilised peripheral blood stem cells are associated with rapid engraftment in multiple myeloma patients receiving autologous transplant 459
A prospective molecular study of chimaerism in patients with haematological malignancies receiving unrelated cord blood or bone marrow transplants: detection of mixed chimaerism predicts graft failure with or without early autologous reconstitution in cord blood recipients 458
Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice 456
High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network. 452
Hematopoietic, Mesenchymal, and Immune Cells Are More Enhanced in Bone Marrow than in Peripheral Blood from Granulocyte Colony-Stimulating Factor Primed Healthy Donors 451
Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation 449
Clinical and metabolic effects of different parenteral nutrition regimens in patients undergoing allogeneic bone marrow transplantation 449
A new system for quality control in hematopoietic progenitor cell units before reinfusion in autologous transplant. 449
Monitoring of KI and WU polyomaviruses in hematopoietic stem cell transplant patients 448
Splenic irradiation before hematopoietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized study 444
Cryotherapy reduces oral mucositis and febrile episodes in myeloma patients treated with high-dose melphalan and autologous stem cell transplant: a prospective, randomized study 440
A fatal case of invasive fungal sinusitis by Scopulariopsis acremonium in a bone marrow transplant recipient 438
Cord blood transplantation in adults with acute myeloid leukaemia. 436
Obstacles to managing chemotherapy-induced nausea and vomiting in high-dose chemotherapy with stem cell transplant 435
Excretion of the novel polyomaviruses KI and WU in the stool of patients with hematological disorders 434
Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study 433
Factors predicting outcome after allogeneic transplant in refractory acute myeloid leukemia: a retrospective analysis of Gruppo Italiano Trapianto di Midollo Osseo (GITMO) 433
Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells 431
The therapeutic use of cord blood 431
The policy of the Rome Transplant Network (RTN), a metropolitan (2009). The Potential Application Of The Allogeneic Transplant By The Policy Of Widespread Donor Search: An Intention-To-Treat Analysis From The Rome Transplant Network. 430
Impact of ABO incompatibility on patient outcome in haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the acute leukemia working party of the EBMT 429
Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus-host disease prophylaxis in haploidentical transplant 429
Pre-transplant manipulation processing of umbilical cord blood units: Efficacy of Rubinstein's thawing technique used in 40 transplantation procedures 428
WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO) 426
Platelet gel for treatment of mucocutaneous lesions related to graft-versus-host disease after allogeneic hematopoietic stem cell transplant 425
Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation 425
Fractionated total body irradiation in allogeneic bone marrow transplantation in leukemia patients: analysis of prognostic factors and results in 136 patients 425
Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remission. 424
Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion 423
The potential role of pre-transplant HBcIgG seroposivity as predictor of clinically relevant cytomegalovirus infection in patients with lymphoma undergoing autologous hematopoietic stem cell transplantation: A study from the Rome Transplant Network 422
Pregnancy and secondary cancer after allogeneic bone marrow transplantation 421
Thrombophilic screening in patients with paroxysmal nocturnal haemoglobinuria: a pilot study 420
Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT 418
A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia 415
3-Tesla MR spectroscopy in patients subjected to bone marrow transplantation: clinical correlations. 414
Ponatinib Induces a Persistent Molecular Response and Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia with a T315I Mutation following Early Relapse after Allogeneic Transplant 414
Thiotepa-based conditioning for allogeneic stem cell transplantation in acute lymphoblastic leukemia—A survey from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation 413
HLA-identical sibling allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning compared to autologous peripheral blood stem cell transplantation for elderly patients with de novo acute myeloid leukemia 412
CD34+ cell mobilization for allogeneic progenitor cell transplantation: efficacy of a short course of G-CSF 412
ALL R-87 protocol in the treatment of children with acute lymphoblastic leukaemia in early bone marrow relapse 411
Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia 411
Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia 411
Increasing risk of relapse after allogeneic stem cell transplant for adult acute lymphoblastic leukemia in > or = 2nd complete remission induced by highly intensive chemotherapy 410
Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia:a retrospective analysis. 409
Cidofovir for BK virus-associated hemorrhagic cystitis: a retrospective study 409
Stem cell transplantation for chronic myeloid leukemia in children 407
Hospital cluster of HBV infection: molecular evidence of patient-to-patient transmission through lancing device 407
The Rome Transplant Network model compared to the Italian Bone Marrow Donor Registry activity for unrelated donor search process and transplant efficiency for hematologic malignancy 403
Cytogenetic and molecular diagnostic characterization combined to post-consolidation minimal residual disease assessment by flow-cytometry improves risk stratification in adult acute myeloid leukemia 402
ABO-incompatible bone marrow transplantation: a GITMO survey of current practice in Italy and comparison with the literature 402
Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia. 401
Gastrointestinal surgical emergencies in patients treated for hemathological malignancies 401
Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group 401
Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia 399
Relevance of bone marrow cell dose on allogeneic transplantation outcomes for patients with acute myeloid leukemia in first complete remission: results of a European survey 399
Impact of Graft-versus-Host Disease Prophylaxis on Outcomes after Myeloablative Single-Unit Umbilical Cord Blood Transplantation 399
Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: a European Group for Blood and Marrow Transplantation, Société Française de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Research Center Collaborative Study 398
Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: influence of dose and stem cell source shows better outcome with rich marrow 397
Algorithm for donor selection in 2011 397
Reduced intensity allogeneic transplantation in primary cutaneous t-cell lymphomas. 397
Matched and mismatched unrelated donor compared to autologous stem cell transplantation for acute myeloid leukemia in first complete remission: a retrospective, propensity score-weighted analysis from the ALWP of the EBMT 397
Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation 396
Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignancies 396
Clinical and biological aspects of acute monocytic leukemia (a retrospective study of 29 patients) 395
Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study 393
N-acetylcysteine in the treatment of steroid-resistant acute graft-versus-host-disease: preliminary results. Gruppo Italiano Trapianto di Midollo Osseo (GITMO) 390
High-dose therapy and autologous stem-cell transplantation in waldenstrom macroglobulinemia: the lymphoma working party of the european group for blood and marrow transplantation 390
Standard- versus high-dose lenograstim in adults with hematologic malignancies for peripheral blood progenitor cell mobilization. 389
Allogeneic stem cell transplant from HLA-identical sibling for chronic granulomatous disease and review of the literature 389
Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia 386
Unrelated donor marrow transplantation: an update of the experience of the Italian Bone Marrow Group (GITMO) 386
Bone mass, bone metabolism, and prevalence of spinal fractures in recipients of allogenic bone marrow transplantation for leukemia 385
Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patients 385
Monitoring of minimal residual disease in acute myeloid leukemia 384
Does the volume reduction manipulation before cryopreservation influence cord blood cell recovery pretransplant? 384
HLA-C and HLA-DQB1 compatibility in unrelated cord blood transplants 384
Assessment of donor-derived kir by sequential cDNA genotyping in non t cell depleted haploidentical stem cell transplanted patients 384
Umbilical Cord Blood Transplantation From Unrelated Donors In Patients With Ph-Positive Acute Lymphoblastic Leukemia. 384
Development of cellulitis caused by Aeromonas hydrophila in allogeneic hematopoietic transplantation: a case report. 383
Total parenteral nutrition enriched with glutamine and ω-3 fatty acid in adult patients undergoing autologous stem cell transplantation. 383
Management of advanced acute lymphoblastic leukemia in children and adults: results of the ALL R-87 protocol. AIEOP and GIMEMA Cooperative Groups 382
Monitoring treatment and survival in chronic myeloid leukemia. Italian Cooperative Study Group on Chronic Myeloid Leukemia and Italian Group for Bone Marrow Transplantation 382
The potential role of pre-transplant HBcIgG seroposivity as predictor of clinically relevant cytomegalovirus infection in patients with lymphoma undergoing autologous hematopoietic stem cell transplantation: A study from the Rome Transplant Network. 380
Minimal Residual Disease in Acute Myeloid Leukemia of Adults: Determination, Prognostic Impact and Clinical Applications 380
Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis 379
Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation 379
Extracorporeal photochemotherapy in the treatment of acute and chronic GvHD: experience from Rome Transplant Network 379
Cryptosporidiosis in patients with hematologic malignancies 378
Killer Cell Immunoglobulin-Like Receptor-Ligand Matching and Outcomes after Unrelated Cord Blood Transplantation in Acute Myeloid Leukemia 378
Allogeneic stem cell transplantation for patients with advanced primary cutaneous T-cell lymphoma 377
Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO 376
Totale 42.061
Salva come PNG Salva come JPEG
Categoria #
all - tutte 178.083
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 178.083
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215.431 0 0 0 0 0 1.465 1.626 1.219 259 358 401 103
2021/20222.451 109 368 110 102 66 193 141 138 143 154 169 758
2022/20232.761 353 240 134 263 172 658 326 134 214 17 189 61
2023/20241.016 101 47 78 25 101 237 58 39 28 23 16 263
2024/20255.359 170 1.248 572 318 66 226 450 213 543 584 468 501
2025/20263.682 578 503 1.075 684 703 139 0 0 0 0 0 0
Totale 77.569